tiprankstipranks
Argenx price target raised to $696 from $606 at JMP Securities
PremiumThe FlyArgenx price target raised to $696 from $606 at JMP Securities
1M ago
Argenx SE Outlines 2025 Strategic Priorities Amid Strong Sales
Premium
Company Announcements
Argenx SE Outlines 2025 Strategic Priorities Amid Strong Sales
1M ago
Argenx reports preliminary Q4 revenue $737M, consensus $627.99M
Premium
The Fly
Argenx reports preliminary Q4 revenue $737M, consensus $627.99M
1M ago
Argenx announces Japan MHLW approval for Vyvdura for CIDP
PremiumThe FlyArgenx announces Japan MHLW approval for Vyvdura for CIDP
2M ago
Argenx price target raised to $723 from $639 at Wells Fargo
Premium
The Fly
Argenx price target raised to $723 from $639 at Wells Fargo
2M ago
Argenx price target raised to EUR 740 from EUR 620 at JPMorgan
Premium
The Fly
Argenx price target raised to EUR 740 from EUR 620 at JPMorgan
3M ago
Argenx SE Boosts Myositis Treatment Development
PremiumCompany AnnouncementsArgenx SE Boosts Myositis Treatment Development
3M ago
Argenx to continue development of efgartigimod subcutaneous
Premium
The Fly
Argenx to continue development of efgartigimod subcutaneous
3M ago
Argenx and Zai Lab’s CIDP Drug Approved in China
Premium
Company Announcements
Argenx and Zai Lab’s CIDP Drug Approved in China
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100